Deal for Forest Fantastic for Pharma ETFs

Shares of drugmaker Forest Laboratories (NYSE: FRX) are up more than 29% Tuesday after the company received a $25 billion cash and stock takeover offer from generic drugmaker Actavis (NYSE: ACT). Not that they need it, but news of the Actavis/Forest marriage is predictably proving to be a boon for...